Abstract:Salmonella are common enteric bacterial pathogens that infect both humans and animals. Intestinal epithelial barrier, formed by a single layer of epithelial cells and apical junctional complex (AJC), plays a crucial role in host defense against enteric pathogens to prevent bacterial translocation. However, the underlying mechanisms of intestinal epithelial barrier dysfunction caused by Salmonella are poorly understood. It is found that a locus termed Salmonella plasmid virulence ( spv ) gene exists extensively in clinically important Salmonella serovars. SpvB is a key effector encoded within this locus, and closely related to Salmonella pathogenicity such as interfering with autophagy and iron homeostasis. To investigate the interaction between SpvB and intestinal epithelial barrier and elucidate the underlying molecular mechanism, we used the typical foodborne disease agent Salmonella enterica serovar Typhimurium ( Salmonella typhimurium ) carrying spvB or not to construct infection models in vivo and in vitro . C57BL/6 mice were orally challenged with S. typhimurium wild-type strain SL1344 or spvB -deficient mutant strain SL1344-Δ spvB . Caco-2 cell monolayer model, as a widely used model to mimic the human intestinal epithelium in vitro , was infected with SL1344, SL1344-Δ spvB , or spvB complementary strain SL1344-c-Δ spvB , respectively. The results showed that SpvB enhanced bacterial pathogenicity during S. typhimurium infection in vivo , and contributed to intestinal epithelial barrier dysfunction in both infection systems. This SpvB-mediated barrier dysfunction was attributed to the cellular redistribution of Claudin-1, Occludin, and E-cadherin junctional proteins. Moreover, by using pharmacological inhibitors, we found that F-actin rearrangement and suppression of protein kinase C (PKC) signaling pathway were involved in SpvB-mediated barrier dysfunction. In conclusion, the study reveals the contribution of Salmonella effector SpvB to the dysfunction of intestinal epithelial barrier integrity, which facilitates bacterial translocation via the paracellular route to promote Salmonella systemic dissemination. Our findings broaden the understanding of host–pathogen interactions in salmonellosis, and provide new strategies for the therapy in limiting bacterial dissemination during infection.

Salmonella Outer Protein B Suppresses Colitis Development Via Protecting Cell from Necroptosis.

Phosphatase-independent suppression of mucosal inflammation and disease progression by Salmonella SopB

The Salmonella effector SopB prevents ROS-induced apoptosis of epithelial cells by retarding TRAF6 recruitment to mitochondria

Cirtical role for Salmonella effector SopB in regulating inflammasome activation.

Salmonella pSLT-encoded effector SpvB promotes RIPK3-dependent necroptosis in intestinal epithelial cells

Salmonella Infantis Delays the Death of Infected Epithelial Cells to Aggravate Bacterial Load by Intermittent Phosphorylation of Akt With SopB

<i>Salmonella</i> Infantis Delays the Death of Infected Epithelial Cells to Aggravate Bacterial Load by Intermittent Phosphorylation of Akt With <i>SopB</i>

The Salmonella effector protein SopD targets Rab8 to positively and negatively modulate the inflammatory response

Deceiving The Big Eaters: Salmonella Typhimurium SopB subverts host cell Xenophagy through Akt-TFEB axis in macrophages

The SseL Protein Inhibits the Intracellular NF-κB Pathway to Enhance the Virulence of Salmonella Pullorum in a Chicken Model.

Salmonella effector SopD promotes plasma membrane scission by inhibiting Rab10

Salmonella spvC Gene Inhibits Pyroptosis and Intestinal Inflammation to Aggravate Systemic Infection in Mice

Salmonella effector SseL induces PD-L1 up-regulation and T cell inactivation via beta-catenin signalling axis

The secreted effector protein of Salmonella dublin, SopA, is translocated into eukaryotic cells and influences the induction of enteritis

Salmonella effector SopB reorganizes cytoskeletal vimentin to maintain replication vacuoles for efficient infection

Non-Hematopoietic MLKL Protects Against Salmonella Mucosal Infection by Enhancing Inflammasome Activation

Salmonella Effector SpvB Disrupts Intestinal Epithelial Barrier Integrity for Bacterial Translocation

SalmonellaTyphimurium Effector SseI Regulates Host Peroxisomal Dynamics to Acquire Lysosomal Cholesterol for Better Intracellular Growth

Salmonella spvC Gene Inhibits Autophagy of Host Cells and Suppresses NLRP3 as Well as NLRC4

The Salmonella SPI1 effector SopB stimulates nitric oxide production long after invasion

Identification of a Novel Salmonella Type III Effector by Quantitative Secretome Profiling.